These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33215839)

  • 1. Glycaemic trajectory and predictors of suboptimal glycaemic control in people with type 2 diabetes.
    Pathiraja NP; Colman PG; Wentworth JM
    Intern Med J; 2020 Nov; 50(11):1415-1418. PubMed ID: 33215839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
    Bonnet F; Chen H; Cooper A; Gomes MB; Ji L; Leigh P; Ramirez L; Shestakova MV; Shimomura I; Siddiqui A; Tang F; Vora J; Watada H; Khunti K
    Diabetes Obes Metab; 2021 Oct; 23(10):2336-2343. PubMed ID: 34212481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
    Khunti K; Chen H; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Ji L; Kosiborod M; Pocock S; Shestakova MV; Shimomura I; Tang F; Watada H; Nicolucci A;
    Diabetes Obes Metab; 2020 Jan; 22(1):66-78. PubMed ID: 31468637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term tolerance and efficacy of adjunctive exenatide therapy on glycaemic control and bodyweight in type 2 diabetes: a retrospective study from a specialist diabetes outpatient clinic.
    Carrington MJ; Chan YK; Stewart S; Sjouke B; Brazilek R; Cohen N
    Intern Med J; 2014 Apr; 44(4):345-53. PubMed ID: 24877253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to medication, glycaemic control and hospital attendance in young adults with type 2 diabetes.
    Kunasegaran S; Beig J; Khanolkar M; Cundy T
    Intern Med J; 2018 Jun; 48(6):728-731. PubMed ID: 29898267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of adherence to Mediterranean diet and/or drug treatment on glycaemic control in type 2 diabetes mellitus patients: DM2-CUMCYL study.
    Sánchez-Hernández MS; Rodríguez-Caldero MC; Martín-Pérez MP; Mira-Solves JJ; Vitaller-Burillo J; Carratalá-Munuera MC
    Prim Care Diabetes; 2020 Dec; 14(6):685-691. PubMed ID: 32674912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
    Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
    [No Abstract]   [Full Text] [Related]  

  • 9. Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER study.
    Ling S; Sun P; Zaccardi F; Khosla S; Cooper A; Fenici P; Khunti K
    Diabetes Obes Metab; 2020 May; 22(5):828-837. PubMed ID: 31944528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control of Asian patients with type-2 diabetes mellitus on tiered up-titration of metformin monotherapy: A one-year real-world retrospective longitudinal study in primary care.
    Gao Q; Tan NC; Fang HSA; Lee ML; Hsu W
    Diabetes Res Clin Pract; 2022 May; 187():109874. PubMed ID: 35436547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia.
    Rätsep A; Kalda R; Lember M
    Eur J Gen Pract; 2010 Jun; 16(2):85-91. PubMed ID: 20429704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data.
    Hellgren M; Svensson AM; Franzén S; Ericsson Å; Gudbjörnsdottir S; Ekström N; Bertilsson R; Valentine W; Malkin S
    Diabetes Obes Metab; 2021 Jul; 23(7):1604-1613. PubMed ID: 33729661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.
    Goudswaard AN; Stolk RP; Zuithoff P; Rutten GE
    Eur J Epidemiol; 2004; 19(6):541-5. PubMed ID: 15330126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prior internist encounter on glycaemic control among patients with type 2 diabetes mellitus at a family practice setting in Nigeria.
    Michael GC; Grema BA; Abdulkadir Z; Ibrahim H; Haruna AI
    Niger Postgrad Med J; 2023; 30(2):110-118. PubMed ID: 37148112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real-life clinical practice.
    Alvarez-Guisasola F; Cebrián-Cuenca AM; Cos X; Ruiz-Quintero M; Millaruelo JM; Cahn A; Raz I; Orozco-Beltrán D;
    Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29271560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
    van Dieren S; Kengne AP; Chalmers J; Beulens JW; Davis TM; Fulcher G; Heller SR; Patel A; Colagiuri S; Hamet P; Mancia G; Marre M; Neal B; Williams B; Peelen LM; van der Schouw YT; Woodward M; Zoungas S
    Diabetes Obes Metab; 2014 May; 16(5):426-32. PubMed ID: 24251579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Much Do We Know about the Biopsychosocial Predictors of Glycaemic Control? Age and Clinical Factors Predict Glycaemic Control, but Psychological Factors Do Not.
    Abdullah MFILB; Sidi H; Ravindran A; Gosse PJ; Kaunismaa ES; Mainland RL; Mustafa N; Hatta NH; Arnawati P; Zulkifli AY; Woon LS
    J Diabetes Res; 2020; 2020():2654208. PubMed ID: 32455131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela.
    G Duarte F; da Silva Moreira S; Almeida MDCC; de Souza Teles CA; Andrade CS; Reingold AL; Moreira ED
    BMJ Open; 2019 Mar; 9(3):e023401. PubMed ID: 30842107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.